Endpoints News 2026-01-21 J&J praises new FDA guidance to speed development of multiple myeloma drugs
Endpoints News 2026-01-21 Fosun-funded Hygtia Therapeutics licenses Insilico’s NLRP3 inhibitor for Parkinson’s
Endpoints News 2026-01-20 EU Parliament adopts stricter drug stockpiling rules under Critical Medicines Act
Endpoints News 2026-01-20 Exciva raises $59M Series B to fund Phase 2 test of Alzheimer’s agitation drug